LARIMAR THERAPEUTICS INC
LRMRNASDAQ🏆 #2825 by market capEarnings Nov 5US Equity
$4.28▼ $0.03 (−0.70%)
Live1h▼ 1.0%
24h▼ 0.7%
7d▲ 4.4%
14d▲ 18.2%
30d▲ 14.9%
1y▲ 15.7%
🏦Market Cap
$445M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
62
Fair
📊
Analyst Ratings
Price
$4.28
Total
8
Raised
1
Lowered
0
Avg PT
$8.00
H / L
$11 / $5
| Institution | Action | Rating | Date |
|---|---|---|---|
Wedbush | Reiterated | Outperform | 2026-08-05 |
Baird | Reiterated | Outperform | 2026-06-30 |
Citigroup | Reiterated | Buy | 2026-02-25 |
Oppenheimer | Reiterated | Outperform | 2025-10-02 |
JMP Securities | Reiterated | Market Outperform | 2025-08-19 |
Guggenheim | Reiterated | Buy | 2025-06-25 |
HC Wainwright & Co. | Reiterated | Buy | 2025-03-25 |
William Blair | Upgraded | Market Perform → Outperform | 2022-09-19 |
One row per institution, most recent rating